Recent Advances of Emerging Spleen‐Targeting Nanovaccines for Immunotherapy
Advanced Healthcare Materials · 2023-09 · 12 (23)
DOI: 10.1002/adhm.202300351 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.06.2023. Verfasst von Xuanyi He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Shanghai, 200240, Chi…. Hauptthemen laut MEDLINE: Vaccines, Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 142 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Vaccines provide a powerful tool to modulate the immune system for human disease prevention and treatment. Classical vaccines mainly initiate immune responses in the lymph nodes (LNs) after subcutaneous injection. However, some vaccines suffer from inefficient delivery of antigens to LNs, undesired inflammation, and slow immune induction when encountering the rapid proliferation of tumors. Alternatively, the spleen, as the largest secondary lymphoid organ with a high density of antigen‐presenting cells (APCs) and lymphocytes, acts as an emerging target organ for vaccinations in the body. Upon intravenous administration, the rationally designed spleen‐targeting nanovaccines can be internalized by the APCs in the spleen to induce selective antigen presentation to T and B cells in their specific sub‐regions, thereby rapidly boosting durable cellular and humoral immunity. Herein, the recent advances of spleen‐targeting nanovaccines for immunotherapy based on the anatomical architectures and functional zones of the spleen, as well as their limitations and perspectives for clinical applications are systematically summarized. The aim is to emphasize the design of innovative nanovaccines for enhanced immunotherapy of intractable diseases in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Shanghai, 200240, China.
ORCID-Profile: Xiangzhao Ai
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, X., Wang, J., Tang, Y., Chiang, S. T., Han, T., Chen, Q., Qian, C., Shen, X., Li, R., & Ai, X. (2023). Recent Advances of Emerging Spleen‐Targeting Nanovaccines for Immunotherapy. Advanced Healthcare Materials, 12(23). https://doi.org/10.1002/adhm.202300351
Vancouver
He X, Wang J, Tang Y, Chiang ST, Han T, Chen Q, et al. Recent Advances of Emerging Spleen‐Targeting Nanovaccines for Immunotherapy. Advanced Healthcare Materials. 2023;12(23). doi:10.1002/adhm.202300351
BibTeX
@article{He2023,
author = {He, Xuanyi and Wang, Jing and Tang, Yuqing and Chiang, Seok Theng and Han, Tianzhen and Chen, Qi and Qian, Chunxi and Shen, Xiaoshuai and Li, Rongxiu and Ai, Xiangzhao},
title = {Recent Advances of Emerging Spleen‐Targeting Nanovaccines for Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {23},
doi = {10.1002/adhm.202300351}
}
EUVIMED